MAT:NASDAQMattel, Inc. Analysis
Data as of 2026-04-16 - not real-time
$14.84
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Mattel shares are trading well below the discounted cash‑flow estimate, offering roughly thirty percent upside potential. The short‑term moving average sits beneath the longer‑term average, confirming a bearish technical alignment, while the RSI hovers around the midpoint and the MACD histogram has turned positive, hinting at a possible near‑term bounce. Volume has been on a downtrend, and the beta exceeds one, suggesting higher price swings than the market, compounded by a volatility figure above twenty percent. The stock is perched near a key support level and faces resistance just above the current price, framing a tight trading range.
Fundamentally, the company posted solid revenue growth and maintains healthy gross and operating margins, with cash flow generation that comfortably covers debt service despite a high leverage ratio. Analysts collectively rate the stock as a buy, and management’s recent presentation at a major consumer conference underscored confidence in the brand portfolio, though a pending shareholder litigation adds a layer of regulatory risk.
Fundamentally, the company posted solid revenue growth and maintains healthy gross and operating margins, with cash flow generation that comfortably covers debt service despite a high leverage ratio. Analysts collectively rate the stock as a buy, and management’s recent presentation at a major consumer conference underscored confidence in the brand portfolio, though a pending shareholder litigation adds a layer of regulatory risk.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- bearish technical alignment with moving averages
- proximity to support level
- decreasing trading volume
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- significant upside to fair value
- steady revenue growth and margin expansion
- positive analyst consensus
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- strong brand portfolio and strategic outlook
- undervalued relative to intrinsic value
- robust cash flow supporting long‑term investments
Key Metrics & Analysis
Financial Health
Revenue Growth7.30%
Profit Margin7.43%
P/E Ratio12.0
ROE17.68%
ROA5.56%
Debt/Equity120.16
P/B Ratio2.0
Op. Cash Flow$593.3M
Free Cash Flow$393.7M
Technical Analysis
TrendBearish
RSI43.4
Support$14.10
Resistance$15.72
MA 20$14.64
MA 50$16.31
MA 200$18.40
MACDBullish
VolumeDecreasing
Fear & Greed Index88.98
Valuation
Fair Value$19.45
Target Price$19.14
Upside/Downside29.00%
GradeUndervalued
TypeBlend
Risk Assessment
Beta1.21
Volatility24.00%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.